Health care costs of cardiovascular disease in China: a machine learning-based cross-sectional study

Mengjie Lu1,2, Hong Gao3, Chenshu Shi2

  • 1School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Frontiers in Public Health
|November 29, 2023
PubMed

Insights

High healthcare costs for cardiovascular disease (CVD) in China are linked to older age, male sex, longer hospital stays, and specific conditions like heart failure. Machine learning identified these key cost determinants.

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Medical Informatics

Background:

  • Cardiovascular disease (CVD) imposes a significant financial burden on patients, households, and China's healthcare system.
  • Understanding the factors driving healthcare cost variations in CVD patients is crucial for financial relief.

Purpose of the Study:

  • To identify and rank the primary determinants of healthcare costs in Chinese CVD patients.
  • To assess the impact of these determinants on the overall distribution of CVD-related healthcare expenses.

Main Methods:

  • Utilized data from 28,213 CVD patients surveyed in 14 tertiary hospitals in China (2018-2020).
  • Employed re-centered influence function regression for cost concentration analysis.
  • Applied quantile regression forests (a machine learning approach) to pinpoint factors influencing low, median, and high healthcare costs.

Main Results:

  • The 10th, 50th, and 90th quantiles of healthcare costs were 6,103 CNY, 18,105 CNY, and 98,637 CNY, respectively.
  • Factors associated with higher costs included older age, male sex, longer hospital stays, more comorbidities, complex procedures, and emergency admissions.
  • Specific CVD types like cardiomyopathy, heart failure, and stroke were linked to increased healthcare expenditures.

Conclusions:

  • Machine learning effectively identifies key determinants of CVD healthcare costs in China.
  • Findings can inform policy interventions to mitigate the financial impact of CVD, especially for high-cost patients.
Abstract